Literature DB >> 33637099

RETRACTED ARTICLE: Circular RNA ABCB10 promotes hepatocellular carcinoma progression by increasing HMG20A expression by sponging miR-670-3p.

Yu Fu1, Limin Cai2, Xuexue Lei1, Dunwei Wang3.   

Abstract

BACKGROUND/AIMS: The dysregulation of circABCB10 may play an critical role in tumor progression. However, its function in liver cancer (HCC) is still unclear. Therefore, this experimental design is based on circABCB10 to explore the pathogenesis of HCC.
METHODS: The expression of circABCB10 and miR-670-3p in HCC tissues was detected by RT-qPCR. CCK-8, Brdu incorporation, colony formation and transwell assays were used to determine the effect of circABCB10 on HCC cell proliferation and migration. Target gene prediction and screening, luciferase reporter assays were used to validate downstream target genes of circABCB10 and miR-670-3p. HMG20A expression was detected by RT-qPCR and Western blotting. The tumor changes in mice were detected by in nude mice.
RESULTS: CircABCB10 was significantly increased in HCC tissues and cell lines, and high CircABCB10 expression was directly associated with low survival in HCC patients. Silencing of circABCB10 inhibited proliferation and invasion of hepatocellular carcinoma. In addition, circABCB10 acted as a sponge of miR-670-3p to upregulate HMG20A expression. In addition, overexpression of miR-670-3p or knockdown of HMG20A reversed the carcinogenic effects of circABCB10 in HCC. There was a negative correlation between the expression of circABCB10 and miR-670-3p, and a positive correlation between the expression of circABCB10 and HMG20A in HCC tissues.
CONCLUSION: circABCB10 promoted HCC progression by modulating the miR-670-3p/HMG20A axis, and circABCB10 may be a potential therapeutic target for HCC. Trail registration JL1H384739, registered at Sep 09, 2014.

Keywords:  HMG20A; Liver cancer; Proliferation; circABCB10; miR-670-3p

Year:  2019        PMID: 33637099     DOI: 10.1186/s12935-019-1055-z

Source DB:  PubMed          Journal:  Cancer Cell Int        ISSN: 1475-2867            Impact factor:   5.722


  28 in total

1.  A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria.

Authors:  Olivier Seror; Gisele N'Kontchou; Nathalie Ganne; Michel Beaugrand
Journal:  Ann Surg       Date:  2011-11       Impact factor: 12.969

Review 2.  Liver cancer in 2013: Mutational landscape of HCC--the end of the beginning.

Authors:  Augusto Villanueva; Josep M Llovet
Journal:  Nat Rev Clin Oncol       Date:  2014-01-07       Impact factor: 66.675

3.  Analysis of intron sequences reveals hallmarks of circular RNA biogenesis in animals.

Authors:  Andranik Ivanov; Sebastian Memczak; Emanuel Wyler; Francesca Torti; Hagit T Porath; Marta R Orejuela; Michael Piechotta; Erez Y Levanon; Markus Landthaler; Christoph Dieterich; Nikolaus Rajewsky
Journal:  Cell Rep       Date:  2014-12-31       Impact factor: 9.423

4.  Using circular RNA as a novel type of biomarker in the screening of gastric cancer.

Authors:  Peifei Li; Shengcan Chen; Huilin Chen; Xiaoyan Mo; Tianwen Li; Yongfu Shao; Bingxiu Xiao; Junming Guo
Journal:  Clin Chim Acta       Date:  2015-02-14       Impact factor: 3.786

Review 5.  Surgical resection and liver transplantation for hepatocellular carcinoma.

Authors:  Mohamed E Akoad; Elizabeth A Pomfret
Journal:  Clin Liver Dis       Date:  2015-03-02       Impact factor: 6.126

6.  Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets.

Authors:  Sandrine Boyault; David S Rickman; Aurélien de Reyniès; Charles Balabaud; Sandra Rebouissou; Emmanuelle Jeannot; Aurélie Hérault; Jean Saric; Jacques Belghiti; Dominique Franco; Paulette Bioulac-Sage; Pierre Laurent-Puig; Jessica Zucman-Rossi
Journal:  Hepatology       Date:  2007-01       Impact factor: 17.425

7.  Circular RNA circ-ABCB10 promotes breast cancer proliferation and progression through sponging miR-1271.

Authors:  Hai-Feng Liang; Xing-Zeng Zhang; Bao-Guo Liu; Guo-Tao Jia; Wen-Lei Li
Journal:  Am J Cancer Res       Date:  2017-07-01       Impact factor: 6.166

8.  Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production.

Authors:  Willscott E Naugler; Toshiharu Sakurai; Sunhwa Kim; Shin Maeda; Kyounghyun Kim; Ahmed M Elsharkawy; Michael Karin
Journal:  Science       Date:  2007-07-06       Impact factor: 47.728

9.  Hsa_circ_0001649: A circular RNA and potential novel biomarker for hepatocellular carcinoma.

Authors:  Meilin Qin; Gang Liu; Xisong Huo; Xuemei Tao; Xiaomeng Sun; Zhouhong Ge; Juan Yang; Jia Fan; Lei Liu; Wenxin Qin
Journal:  Cancer Biomark       Date:  2016       Impact factor: 4.388

10.  Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model.

Authors:  Janaiah Kota; Raghu R Chivukula; Kathryn A O'Donnell; Erik A Wentzel; Chrystal L Montgomery; Hun-Way Hwang; Tsung-Cheng Chang; Perumal Vivekanandan; Michael Torbenson; K Reed Clark; Jerry R Mendell; Joshua T Mendell
Journal:  Cell       Date:  2009-06-12       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.